“Expedited Filings and their CMC Implications: Considerations toward Better Planning”
(Phoenixville, PA; September 20, 2019) – Design Space InPharmatics, llc. (DSI) Drug Substance Development Expert, Dr. James Mencel, will be presenting “Expedited Filings and their CMC Implications: Considerations toward Better Planning”, sponsored by AMRI, a global contract research and manufacturing organization. Conference sessions will occur at AMRI’s Corporate Headquarters.
Jim will co-moderate the roundtable discussion with AMRI representatives and industry experts at the upcoming reACTION Scientific Symposium 2019 taking place on September 24-25th in Albany, NY. This beautiful upstate, NY location is just a short drive or train ride from cities like Boston, Montreal, and New York, and is easily accessible via the Albany International Airport.
DSI is a full-service regulatory drug development consulting firm for pharmaceuticals, biologics and new drug and delivery platforms. DSI provides regulatory, technical, and project management consulting services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and next generation therapy products.
Since 2007 we have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence.
Whether advocating CMC strategy, directing CMC operations or developing CMC submission content that represent the best interests of emerging biotech, we focus on the critical CMC issues and build programs that enhance development.
Head of Business Development and Marketing
Design Space InPharmatics, llc. (DSI)
Tel: (855) 805-8402×104